PMDA drug package insert
ユリーフ錠2mg
PMDA Prescription drug · キッセイ薬品工業株式会社 · package insert Jan 26, 2026
Key facts
| Brand names | ユリーフ錠2mg, ユリーフ錠4mg, ユリーフOD錠2mg, ユリーフOD錠4mg |
|---|---|
| Nonproprietary names | シロドシン |
| Companies | 製造販売元／キッセイ薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 選択的α1A遮断薬; 前立腺肥大症に伴う排尿障害改善薬 |
| Therapeutic category codes | 87259 |
| YJ codes | 2590010F1023, 2590010F2020, 2590010F3026, 2590010F4022 |
| Approval numbers | 22000AMX01779000, 22000AMX01780000, 22700AMX00768000, 22700AMX00769000 |
| Package insert edition | 第3版 |
| Package insert date | Jan 26, 2026 |
| PMDA document key | 230034_2590010F1023_1 |
| PMDA company code | 230034 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: